Presenting Author’s Contact Details:
Please provide:
Full first and last name(s)
Email address
Affiliation details: department, institution/hospital, city, state (if relevant), country
Author and Co-Authors’ Details:
Include all co-authors' full names, email addresses, and affiliations. Submissions missing email addresses for any co-author will be rejected.
Preferred Presentation Type:
Oral In-Person
Oral Online
Poster In-Person
Poster Online
Abstract Title:
Titles must be written in UPPER CASE with a maximum length of 25 words. All symbols must be spelled out.
Abstract Text:
Abstracts are limited to 500 words, excluding the title and author details. Tables and figures are permitted in the specified formats.
Abstract Table (Optional):
One table per abstract may be uploaded in DOCX format via the File Upload button. Tables must not exceed 10 columns and 10 rows.
Abstract Image (Optional):
Upload images in JPG, GIF, or PNG format, with each image not exceeding 500 KB and dimensions of 600(w) x 800(h) pixels.
Abstract Topic:
Add one or more abstract topics from the list in the relevant field.
Abstract Structure:
Follow the appropriate structure, based on the nature of your submission, whether it is an Oral or Poster presentation:
Clinical Audit, Prospective Survey, Clinical Study:
Background, Methods, Results, Conclusions.
Literature Review or Guideline Review:
Background and Objective, Methods, Learning Points, Discussion.
Case Report or Case Series:
Background, Case Presentation Summary, Learning Points Discussion.
Content Guidelines:
Ensure your abstract contains comprehensive data and meets international ethical standards.
Define abbreviations and use generic drug names.
Presentations must be balanced and free of commercial content.
Do not include patient identifiers such as names or hospital ID numbers.
Abstracts stating "data will be discussed in the presentation" will be rejected.
Submission and After Successful Submission:
Use the SUBMIT button to save your abstract. Abstracts may be edited until the submission deadline. After this deadline, no changes, including author modifications, will be permitted.
An abstract reference number will be sent to you via email—refer to this number in all related correspondence.
If you do not receive the confirmation email, please check your spam folder before contacting the Secretariat secretariat@ineip.org
Please avoid submitting multiple copies of the same abstract.